Pet sitting marketplace Rover grabs a bone, valued at $1.3 billion in latest SPAC deal
February 11, 2021 at 1:28 pm
Another day, another SPAC. Today, we’ve learned that Seattle online pet sitting marketplace Rover plans to join the public ranks via a merger with True Wind Capital’s SPAC that values the company at a $1.35 billion enterprise valuation.
The deal: Rover will add approximately $325 million to its cash balance as part of a merger with Nebula Caravel Acquisition Corp, a publicly-traded SPAC sponsored by True Wind. That includes $275 million from the SPAC and $50 million from institutional investors via private investments in public equity, also known as a common stock PIPE, which is used to fuel a SPAC as an extra financing round.
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Arya Sciences Acquisition Corp. III ("ARYA" or the "Company") (NASDAQ: ARYA) in connection with the Company's proposed merger with Nautilus Biotechnology, Inc. ("Nautilus"), a privately-held startup mapping human proteins. Under the terms of the merger agreement, ARYA will acquire Nautilus through a reverse merger that will result in Nautilus becoming a becoming a public company traded on the NASDAQ. The transaction implies an enterprise value for the combined company of approximately $350 million.
MedCity News
Nautilus Bio lines up SPAC merger and $350M in funding for proteomics R&D
Nautilus, among the biotechs developing protein analysis tools for drug discovery and diagnostics, already has a partnership with Genentech. As it prepares to go public, Nautilus aims to do for proteomics what Illumina did for genomics.
Shares1
Nautilus Biotechnology is joining the public markets through a merger that provides it with $350 million to ramp up work developing its protein analysis technology for drug discovery and diagnostic applications.
Seattle-based Nautilus is combining with Arya III, a special purpose acquisition company (SPAC), which is a publicly traded entity formed as a vehicle for other companies to go public. The combined company, which will be run by Nautilus’s management, will have a valuation of about $900 million. When the deal closes, Nautilus expects that its shares will trade on the Nasdaq under the stock symbol “NAUT.”
Press release content from Business Wire. The AP news staff was not involved in its creation.
Next-Gen Proteomics Company Nautilus Biotechnology to List on Nasdaq Through Merger with Arya Sciences Acquisition Corp III
February 8, 2021 GMT
SEATTLE & NEW YORK (BUSINESS WIRE) Feb 8, 2021
Nautilus Biotechnology, Inc. (“Nautilus Biotechnology” or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the human proteome, and Arya Sciences Acquisition Corp III (Nasdaq: ARYA) (“Arya III”), a special purpose acquisition company or
SPAC, sponsored by Perceptive Advisors, today announced they have entered into a definitive business combination agreement. Upon closing of the transaction, Arya III will redomicile as a Delaware corporation, be renamed Nautilus Biotechnology, Inc. and its common stock is expected to be listed on Nasdaq under the ticker symbol “NAUT” (the “Combined Company”).
Jeff Bezos-backed startup Nautilus Biotechnology set to go public via SPAC at $900M valuation
February 9, 2021 at 10:12 am
Nautilus Biotechnology co-founders Sujal Patel (left) and Parag Mallick. (Nautilus Photo)
Nautilus Biotechnology, a Seattle-based biotech startup led by Isilon co-founder Sujal Patel, is the latest company to go public using a special purpose acquisition company, or SPAC.
The deal, announced Monday morning, will inject approximately $350 million into Nautilus, which is developing a next-generation platform to analyze the human proteome, or the body’s full set of proteins. It values the company at $900 million.
The company plans to raise $150 million as part of a merger with Arya Sciences Acquisition Corp III, a publicly-traded SPAC sponsored by existing Nautilus investor Perceptive Advisors. As part of the transaction, Nautilus will also reel in $200 million from new and previous backers via private investments in public equity, also known as a common stoc